Article Information
History
- June 1, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Wataru Nakamura1,2,†,
- Makoto Hirata3,4,†,
- Satoyo Oda3,5,
- Kenichi Chiba1,
- Ai Okada1,
- Raúl Nicolás Mateos1,
- Masahiro Sugawa1,
- Naoko Iida1,
- Mineko Ushiama3,6,
- Noriko Tanabe3,
- Hiromi Sakamoto3,6,
- Yosuke Kawai7,
- Katsushi Tokunaga7,
- NCBN Controls WGS Consortium,
- Shinichi Tsujimoto2,
- Norio Shiba2,
- Shuichi Ito2,
- Teruhiko Yoshida3,6 and
- Yuichi Shiraishi1,*
- 1Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan
- 2Department of Pediatrics, Yokohama City University Hospital, Kanagawa, Japan
- 3Division of Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan
- 4Department of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan
- 5Division of Laboratory Medicine, National Cancer Center Hospital, Tokyo, Japan
- 6Department of Clinical Genetics, National Cancer Center Research Institute
- 7Genome Medical Science Project, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo 162-8655, Japan
- ↵*Corresponding author: Yuichi Shiraishi, Ph.D., 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan, E-mail: yuishira{at}ncc.go.jp
↵† These authors equally contributed to this work
Posted June 01, 2023.
A comprehensive workflow for target adaptive sampling long-read sequencing applied to hereditary cancer patient genomes
